Mark Jacobson
Chief Operating Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $575,000 | $4,208,131 |
| 2024 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $552,000 | $4,245,813 |
| 2023 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $530,000 | $4,036,250 |
| 2022 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $483,000 | $3,785,242 |
| 2021 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $409,000 | $4,794,824 |
| 2020 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $375,000 | $2,365,005 |
| 2019 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $310,000 | $1,955,681 |
Earnings-call appearances
-
Goldman Sachs 47th Annual Global Healthcare Conference2026-06-08
Axsome Therapeutics, Inc. (AXSM)
-
Jefferies Global Healthcare Conference2026-06-04
Axsome Therapeutics, Inc. (AXSM)
-
William Blair 46th Annual Growth Stock Conference2026-06-03
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2025 Earnings Call2026-02-23
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-03
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-05
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2024 Earnings Call2025-02-18
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-12
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-06
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2023 Earnings Call2024-02-20
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-06
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-07
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2022 Earnings Call2023-02-27
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-07
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-23
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-02
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-01
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-08
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-09
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-10
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2020 Earnings Call2021-03-01
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-05
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-10
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-08
Axsome Therapeutics, Inc. (AXSM)